Intuitive Surgical, Inc. (NASDAQ:ISRG) is James Hambro & Partners LLP’s 10th Largest Position

James Hambro & Partners LLP decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.0% during the third quarter, HoldingsChannel reports. The firm owned 244,809 shares of the medical equipment provider’s stock after selling 4,980 shares during the period. Intuitive Surgical makes up approximately 5.0% of James Hambro & Partners LLP’s holdings, making the stock its 10th biggest holding. James Hambro & Partners LLP’s holdings in Intuitive Surgical were worth $120,276,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in ISRG. Mirador Capital Partners LP grew its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the last quarter. Advisors Asset Management Inc. grew its stake in shares of Intuitive Surgical by 18.1% during the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock valued at $2,945,000 after buying an additional 1,129 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after buying an additional 76,649 shares during the period. Brookstone Capital Management lifted its stake in shares of Intuitive Surgical by 22.4% in the 2nd quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock valued at $5,340,000 after acquiring an additional 2,289 shares during the last quarter. Finally, M&G Plc boosted its holdings in Intuitive Surgical by 53.5% during the 2nd quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock valued at $2,256,000 after acquiring an additional 1,766 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.4 %

Shares of NASDAQ:ISRG traded down $2.00 during midday trading on Monday, reaching $519.15. The company’s stock had a trading volume of 445,338 shares, compared to its average volume of 1,474,347. The firm has a 50 day moving average of $483.85 and a 200-day moving average of $438.56. The firm has a market capitalization of $184.14 billion, a P/E ratio of 94.07, a PEG ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $523.34.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter in the prior year, the company earned $1.18 earnings per share. The business’s revenue was up 14.5% compared to the same quarter last year. On average, research analysts predict that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $5,441,507.50. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Mark Brosius sold 2,115 shares of Intuitive Surgical stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the completion of the transaction, the insider now directly owns 295 shares of the company’s stock, valued at $145,113.45. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock valued at $25,528,753 in the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a report on Friday. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday. Mizuho raised their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday. Finally, Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.